IFNG and neoplasm: Neutralization of IFN-γ in the media of the activated bulk T lymphocytes by using anti-hIFN-γ mAb (10 μg/ml) prior to the incubation with the tumor cells also significantly reduced tumor cell passage across the in vitro BBB (80 %; p < 0.002, Fig. 5b).